In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
Adam Colborn, JD, of AMCP, discusses the complexities of drug pricing and what policymakers must consider in efforts to ...
While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...
According to the survey cited by NCPA, 60.4% of independent pharmacists are considering not stocking one or more of the first ...
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...
RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback